 FORT LEE, NJ, May 20, 2022 GLOBE NEWSWIRE -- Nuvectis Pharma, Inc. Nuvectis, Company, a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer, will present a company overview at the H.C. Wainwright Global Investment Conference. 